25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds

Letai announces: NCI met FY26 goal of full funding payout

In a post on NCI’s LinkedIn, NCI Director Anthony Letai confirmed that the institute has fully awarded and paid out all of its grant funding for the Fiscal Year 2026.

October 16, 2026

Vol.52 No.38

By Claire Marie Porter

In Brief

AACI opens nominations for Cellular Therapy Initiative and Physician Clinical Leadership Initiative steering committees

AACI is accepting nominations for the Cellular Therapy Initiative and Physician Clinical Leadership Initiative steering committees. This election cycle, AACI will select two CTI Steering Committee members and three new PCLI Steering Committee members, with selected members beginning a three-year term in January 2027.

October 16, 2026

Vol.52 No.38

Clinical Roundup

ACS studies find widening rural-urban survival and mortality gaps for women with breast cancer

Life-saving advances in breast cancer care are failing to reach rural America equally. In two large studies led by the American Cancer Society, scientists found that survival and mortality disparities between rural and urban women diagnosed with breast cancer widened over time in the United States.

October 16, 2026

Vol.52 No.38

Podcast

As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”

As the oncology community waits with bated breath for a possible FDA approval of GRAIL’s Galleri test, NCI Director Anthony Letai has a lot to say about multi-cancer detection tests—particularly Galleri.

October 14, 2026

Podcast

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

“I don’t know of a single grant that left my desk that was not approved and funded,” NCI Director Anthony G. Letai said on this episode of The Cancer Letter Podcast. https://open.spotify.com/episode/2PFYGwliBDYEbxBXFd9MtB?si=95DNBAy0QGSKBX31_uETEA This episode is available on Spotify, Apple Podcasts, and Youtube. Letai recapped his first year as NCI director in conversation with Paul Goldberg,...

October 07, 2026

Conversation with The Cancer Letter

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.

October 02, 2026

Vol.52 No.36

By Paul Goldberg

25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds

YOU MAY BE INTERESTED IN

Letai announces: NCI met FY26 goal of full funding payout

AACI opens nominations for Cellular Therapy Initiative and Physician Clinical Leadership Initiative steering committees

ACS studies find widening rural-urban survival and mortality gaps for women with breast cancer

As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

Renew today!

Subscriber content

Never miss an issue!

Login

25M Americans live outside cancer centers’ catchment areas, AACI-Jefferson study finds

YOU MAY BE INTERESTED IN

Letai announces: NCI met FY26 goal of full funding payout

AACI opens nominations for Cellular Therapy Initiative and Physician Clinical Leadership Initiative steering committees

ACS studies find widening rural-urban survival and mortality gaps for women with breast cancer

As FDA sidesteps the question of Galleri’s clinical benefit, NCI’s Letai has “some concerns”

Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”

Never miss an issue!

Login

With Year One metrics in hand, Letai is ready to “bring it home” in Year Two
“I hope I don’t see any more reports of NCI cutting funding, because it just is not consistent with the facts”